These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 12183849

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging--the Multi-Ethnic Study of Atherosclerosis (MESA).
    Edvardsen T, Rosen BD, Pan L, Jerosch-Herold M, Lai S, Hundley WG, Sinha S, Kronmal RA, Bluemke DA, Lima JA.
    Am Heart J; 2006 Jan; 151(1):109-14. PubMed ID: 16368301
    [Abstract] [Full Text] [Related]

  • 24. Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatment.
    Agabiti-Rosei E.
    Blood Press Suppl; 1997 Jan; 2():13-5. PubMed ID: 9495620
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.
    Jones M, Schenkel B, Just J.
    Int J Cardiol; 2005 Apr 20; 100(2):253-65. PubMed ID: 15823633
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension.
    Brown DW, Giles WH, Croft JB.
    Am Heart J; 2000 Dec 20; 140(6):848-56. PubMed ID: 11099987
    [Abstract] [Full Text] [Related]

  • 29. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents.
    Prisant LM.
    Am J Med; 2008 Aug 20; 121(8 Suppl):S8-15. PubMed ID: 18638617
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide.
    Lokhandwala Y, Damle A.
    Curr Med Res Opin; 2004 May 20; 20(5):639-44. PubMed ID: 15140328
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr 20; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 34. Heart failure in women: a special approach?
    Johnson MR.
    J Heart Lung Transplant; 1994 Apr 20; 13(4):S130-4. PubMed ID: 7947870
    [Abstract] [Full Text] [Related]

  • 35. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007 Apr 20; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 36. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative).
    Oberman A, Prineas RJ, Larson JC, LaCroix A, Lasser NL.
    Am J Cardiol; 2006 Feb 15; 97(4):512-9. PubMed ID: 16461048
    [Abstract] [Full Text] [Related]

  • 37. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T.
    J Hypertens Suppl; 1998 Sep 15; 16(7):S23-9. PubMed ID: 9855028
    [Abstract] [Full Text] [Related]

  • 38. [Early therapeutic intervention in heart failure].
    Klein W, Dusleag J.
    Acta Med Austriaca; 1992 Sep 15; 19(3):73-6. PubMed ID: 1414167
    [Abstract] [Full Text] [Related]

  • 39. Treatment of left ventricular hypertrophy in hypertensive patients.
    Tamargo J, Delpón E, Valenzuela C.
    Eur Heart J; 1993 Nov 15; 14 Suppl J():102-6. PubMed ID: 8281952
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.